Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
 
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size
This article has been cited by
1Clinical meta-analyses of targeted therapies in adenocarcinoma
Emilio Bria,Maria Bonomi,Sara Pilotto,Francesco Massari,Silvia Novello,Matteo Giaj Levra,Giampaolo Tortora,Giorgio Scagliotti
Targeted Oncology.2013;8(1)35
[DOI]
2Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer: a meta-analysis of 17 phase III randomized controlled trials
Wei-Xiang Qi,Shen Fu,Qing Zhang,Xiao-Mao Guo
Current Medical Research and Opinion.2015;31(1)25
[DOI]
3Gefitinib for advanced non-small cell lung cancer
Esther HA Sim,Ian A Yang,Richard Wood-Baker,Rayleen V Bowman,Kwun M Fong
Cochrane Database of Systematic Reviews.2018;2018(1)25
[DOI]
4Cetuximab-based Therapy is Effective in Chemotherapy-nave Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials
Ezzeldin M. Ibrahim,Khaled M. Abouelkhair,Osama A. Al-Masri,Najeeb C. Chaudry,Ghieth A. Kazkaz
Lung.2011;189(3)193
[DOI]
5Indirect comparison of the efficacy and safety of gefitinib and cetuximab-based therapy in patients with advanced non-small-cell lung cancer
JIFENG TANG,HENA ZHANG,JIANZHOU YAN,RONG SHAO
Molecular and Clinical Oncology.2015;3(1)145
[DOI]
  About the journal 
  Editorial Board 
  Saudi Thoracic Society(STS)
  Announcements 
  Most popular articles 
  My Preferences 

Submit Articles

Alerts

Join us

Most pupular articles